Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Blood sugar level wikipedia , lookup
Hemolytic-uremic syndrome wikipedia , lookup
Schmerber v. California wikipedia , lookup
Autotransfusion wikipedia , lookup
Blood transfusion wikipedia , lookup
Blood donation wikipedia , lookup
Jehovah's Witnesses and blood transfusions wikipedia , lookup
Plateletpheresis wikipedia , lookup
Hemorheology wikipedia , lookup
Men who have sex with men blood donor controversy wikipedia , lookup
SYNTHETIC BLOOD Eda idil çoker Blood Need • Blood need for centuries • Water, wine & opium were used as substitutes • Animal to human transfusion • 1818- James Bundell- first human/human blood transfusion • During WWI & WWII blood transfusion was performed to a wider extent. Squires, Jerry E., Artificial Blood, Science, 295, 1002(2002) 2 Why Blood Substitutes? • Diseases * 1 in 500,000 death risk of alogeneic blood transfusion * 1 in 180,000 HepatitisB risk * 1 in 1.6million HIV/AIDS risk * 1 in 1.8million immunodeficiency death risk • Low donation ratio * By 2030, there will be 4 million unit blood deficiency Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 3 Why Blood Substitutes? • Storage Problems • Cross-matching & compatibility testing • Religious issues Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 4 An Ideal Blood Substitute • Working Principle: Mimic oxygen carrying ability of blood Also: • Transferring oxygen to the tissue • Should not be eliminated in kidney • No compatibility • Easy storage Squires, Jerry E., Artificial Blood, Science, 295, 1002(2002) 5 An Ideal Blood Substitute 6 Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) When to use? • In surgeries that requires high amount of blood transfusion • In case of diseases that requires blood change • War times Brown Universty, Biomedical Department; Synthetic Blood Web Page 7 When to use? Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 8 Types Two main types of oxygen carriers: 1. Haemoglobin Based Oxygen Carriers (HBOC) 2. Perfluorocarbon-Based Products (PFCE) Brown Universty, Biomedical Department; Synthetic Blood Web Page 9 HBOC • 2,3 Diphospoglycerate: A product of red blood cell pathway • Cell-free haemoglobin solution * Keeps O2 carrying ability * No cross-matching * Easy sterilization (ultrafiltration) * Long shelf-life Taken from expired donated blood or animal blood Squires, Jerry E., Artificial Blood, Science, 295, 1002(2002) 10 HBOC • First challenge in fabrication: Elimination in kidneys * Crosslinking Hb molecules together * Encapsulating Hb Molecules * Life time: 12h Problems: • Dependency on blood donation • Short life time • May cause high blood pressure& low cardiac output Squires, Jerry E., Artificial Blood, Science, 295, 1002(2002) 11 HBOC Comparison of HBOCs to Transfused Red Blood Cells Attribute Infused HBOCs Onset of Immediate action: Oxygen affinity: Red cell 2,3 DPG not required for oxygen release Oxygen Red cells plus plasma transport: Risk of disease Sterile transmission: pharmaceutical; no leukocyte exposure Storage: Shelf life: Compatibility: Preparation: Viscosity: Duration of action: Transfused Red Cells 2,3-DPG dependent Red cell 2,3 DPG required for oxygen release Red cells only Risk minimize by improved donor selection; leukocyte exposure Room temperature; Refrigeration no loss of efficacy required; progressive loss of efficacy 36 months 42 days Universal Type-specific Ready to use Requires typing and cross-matching Low High Maximum of 3 days Estimated 60 to 90 days Brown Universty, Biomedical Department; Synthetic Blood Web Page 12 HBOC Products Hemopure: (Biopure) • Readily used in South Africa since 2001 • In Phase III clinical trials for FDA approval (filed’02) • Increases O2 diffusion capacity & decrease blood transfusion need. Hemolink: (Hemosol) • Ongoing Phase II trials in US • 2003- Stopping trials due to an imbalance of cardiac events during a surgery PolyHeme: (Northfield) • Phase III trials • Improving survival in vital bleeding cases Brown Universty, Biomedical Department; Synthetic Blood Web Page Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 13 HBOC Comparison of HBOCs: Source: Shelf-life: Storage: Half-life: Approved oxygen therapeutics: Product Name: Biopure Bovine Hgb Northfield Hemosol Expired Expired Human Human RBCs RBCs 3 years 1 year 1 year Room Temperature Refrigerated Refrigerated/ Room Temperature 18-22 hours 24 hours 14 hours 2 0 0 Hemopure & Oxyglobin PolyHeme Hemolink Brown Universty, Biomedical Department; Synthetic Blood Web Page 14 PFCE • • • Oxygen dissolves in PFC solutions Faster oxygen unloading Not soluble in aqueous media, emulsions are prepared * an emulsion like solution Brown Universty, Biomedical Department; Synthetic Blood Web Page Squires, Jerry E., Artificial Blood, Science, 295, 1002(2002) 15 PFCE Problems: • Biodegradibility: * Fluorocarbons stay in the reticuloendothelial system (RES) * Immediate effects are good, but long term effects are more critical. Brown Universty, Biomedical Department; Synthetic Blood Web Page Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 16 PFCE Products Fluosol DA20: (Green Cross Corp., Japan) • First FDA approved artificial blood in 1989 • Milky solution • To be used in cardiac surgeries • Low PFC content, low O2 carrying capacity (20%/volume of the solution was PFC) • Physicians did not approve using • Discontinued production in 1994 Brown Universty, Biomedical Department; Synthetic Blood Web Page Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 17 PFCE Products Oxygent ™ : (Alliance Pharmaceutical Corp.) • Phase II/III trials for FDA approval • Milky solution • Reducing need of blood transfusion • 60%/volume PFC content Oxycyte™ (Synthetic Blood International, Inc) PFCE PHER-02 (Sanguine Corp. ) Brown Universty, Biomedical Department; Synthetic Blood Web Page Henkel Hanke et al. Artificial oxygen Carriers: A Current Review, AAANA Journal, 2007, 75(3) 18 New Aspects • Prof .Dr. Luc Douay of Université Pierre et Marie Curie-Paris has created red blood cells from stem cells to give back the donor. http://www.youtube.com/watch?v=axrSMFiNI3E 19 • Thank you Questions? 20